Antiviral Activity, Pharmacokinetics, and Dose Response of the HIV-1 Integrase Inhibitor GS-9137 (JTK-303) in Treatment-Naive and Treatment-Experienced Patients. Journal of Acquired Immune Deficiency Syndromes, 43(1): 1-5.

In by AHF

Efficacy of the Protease Inhibitors Tipranavir plus Ritonavir in Treatment-Experienced Patients: 24-Week Analysis from the RESIST-1 Trial. Clinical Infectious Diseases, 43(10): 1337-1346.
The Safety and Efficacy of Dose-Sparing Intradermal Administration of Influenza Vaccine in Human Immunodeficiency Virus–Positive Patients. Archives of Internal Medicine, (166)13: 1417.
Download
File Type: pdf
File Size: 162 KB
Categories: 2006
Tags: 1999-2009
Author: Berger D, Cheng AK, Cohen C, DeJesus E, Elion R, Farthing C, Hawkins T, Kearney BP, Markowitz M, McColl D, Ruane P, Zhong L